Literature DB >> 29414641

Lactobacillus plantarum AN1 cells increase caecal L. reuteri in an ICR mouse model of dextran sodium sulphate-induced inflammatory bowel disease.

Yasushi Yokota1, Ayane Shikano1, Takashi Kuda2, Moemi Takei1, Hajime Takahashi1, Bon Kimura1.   

Abstract

To clarify the different effects of live and heat-killed probiotics on inflammatory bowel disease (IBD), the anti-inflammatory and protective effects of Lactobacillus plantarum AN1 cells isolated from the fermented fish aji-narezushi on murine macrophage RAW264.7 cells and in ICR mice with dextran sodium sulphate (DSS)-induced IBD were determined. L. plantarum AN1 cells showed anti-inflammatory activities in vitro, indicated by secretion of nitric oxide (NO) from RAW264.7 cells in the presence and absence of Escherichia coli 0111 lipopolysaccharide (LPS). L. plantarum AN1 cells also protected RAW264.7 cells against hydrogen peroxide toxicity. There was no difference between these effects in heat-killed and ultraviolet irradiation-killed cells. In the murine IBD model, both live and heat-killed L. plantarum AN1 cells via drinking water tended to ameliorate atrophy of colon length, mucosal tissue damage, and spleen enlargement. Amplicon sequencing of 16S rDNA (V4) revealed that both live and heat-killed AN1 cells increased abundance of indigenous lactic acid bacteria, particularly Lactobacillus reuteri. The results suggest that increased indigenous lactic acid bacterial abundance and feeding with L. plantarum AN1 cells synergistically improve effects against IBD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gut microbiota; IBD; ICR mice; Lactobacillus plantarum; Lactobacillus reuteri; Pyrosequencing

Mesh:

Substances:

Year:  2018        PMID: 29414641     DOI: 10.1016/j.intimp.2018.01.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Effects of fermented green-loofah and green-papaya on nitric oxide secretion from murine macrophage raw 264.7 cells.

Authors:  Ayane Shikano; Takashi Kuda; Hajime Takahashi; Bon Kimura
Journal:  Mol Biol Rep       Date:  2018-07-16       Impact factor: 2.316

Review 2.  Application of vitamin-producing lactic acid bacteria to treat intestinal inflammatory diseases.

Authors:  Jean Guy LeBlanc; Alejandra de Moreno de LeBlanc; Romina Levit; Graciela Savoy de Giori
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-28       Impact factor: 4.813

3.  In vitro antioxidant, anti-glycation and immunomodulation activities of fermented blue-green algae Aphanizomenon flos-aquae.

Authors:  Miyu Taniguchi; Takashi Kuda; Junna Shibayama; Tetsuya Sasaki; Toshihide Michihata; Hajime Takahashi; Bon Kimura
Journal:  Mol Biol Rep       Date:  2019-01-29       Impact factor: 2.316

4.  Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice.

Authors:  Peter Allan Dobranowski; Chris Tang; Jean Philippe Sauvé; Susan Christine Menzies; Laura May Sly
Journal:  Gut Microbes       Date:  2019-02-13

5.  The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice.

Authors:  Le Su; Feifan Ma; Zaiyong An; Xiuyu Ji; Ping Zhang; Qiulin Yue; Chen Zhao; Xin Sun; Kunlun Li; Baojun Li; Xinli Liu; Lin Zhao
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 5.640

Review 6.  Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.

Authors:  Mohammad Al Mijan; Beong Ou Lim
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

Review 7.  Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways.

Authors:  Aida Kamalian; Masoud Sohrabi Asl; Mahsa Dolatshahi; Khashayar Afshari; Shiva Shamshiri; Nazanin Momeni Roudsari; Saeideh Momtaz; Roja Rahimi; Mohammad Abdollahi; Amir Hossein Abdolghaffari
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.